Latest From Hannah Daniel
DOJ Files Preliminary Injunction Against Neoprene Manufacturer
The US Department of Justice filed an injunction to limit chloroprene emissions from Denka Performance Elastomer, a facility that makes device components as well as other neoprene products.
Industry Supports Transparency On Proposed CMS Prior Authorization Rule
Industry trade groups applaud CMS’s proposal to increase transparency for prior authorization approvals but are asking for expedited timeframes to provide care.
News We’re Watching – FDA Mammography Update, SVB Collapse, Zoll's Data Breach, And More
News we are keeping an eye on this week includes the FDA’s first traditional market authorization for a COVID-19 test and its approval of a new neurological diagnostic. The agency also updated its device shortage list and revised mammography guidelines.
Expert: When It Comes To Personal Information, Digital Health Companies Need To Think Broadly
Hogan Lovells partner Scott Loughlin spoke to Medtech Insight about data privacy for digital health companies in the wake of the FTC’s proposed $7.8m settlement with BetterHelp.
Increase Access To MedTech: AdvaMed’s Priorities For The 118th Congress
AdvaMed’s Medical Innovation Agenda for the 118th Congress emphasizes increased access to medical devices, from reimbursement for breakthrough devices to boosting America’s start-ups to closing the care disparities for underserved communities.
FDA FY 2024 Budget Includes 10% Funding Boost, But No Movement On Diagnostics
The FDA requested a 10% increase in budget authority for FY 2024, but diagnostic reform was left out of the proposal.